HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.108.061366v1 50/8/1371    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Campian, M. E. Articles by Tan, H. L. Search for Related Content PubMed PubMed Citation Articles by Campian, M. E. Articles by Tan, H. L.

Serial Noninvasive Assessment of Apoptosis During Right Ventricular Disease Progression in Rats

¹ Heart Failure Research Center, Academic Medical Center, Amsterdam, The Netherlands; ² Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and ³ Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Correspondence: For correspondence or reprints contact: Hanno L. Tan, Heart Failure Research Center, Academic Medical Center, Meibergdreef 9 1105 AZ, Amsterdam, The Netherlands. E-mail: h.l.tan{at}amc.nl

Right ventricular (RV) function is the major determinant of survival in patients with pulmonary hypertension. Yet, the pathophysiologic basis of RV disease is unresolved. We aimed to study the role of apoptosis in RV disease by monitoring it serially during disease progression using in vivo ^99mTc-annexin-V (^99mTc-annexin) scintigraphy and study whether the reduction in apoptosis resulting from chronic treatment with valsartan can be detected by ^99mTc-annexin scintigraphy. Methods: RV disease after pulmonary hypertension was induced by monocrotaline injection in rats. The following 3 groups were studied: rats treated with monocrotaline (monocrotaline rats), rats treated with monocrotaline plus valsartan (valsartan rats), and age-matched controls (control rats). Serial echocardiography and in vivo ^99mTc-annexin scintigraphy were performed. Apoptosis was confirmed by ^99mTc-annexin autoradiography and terminal deoxynucleotidyl-transferase–mediated dUTP nick-end labeling. Fibrosis was assessed by picrosirius red staining. Results: In monocrotaline rats, in vivo ^99mTc-annexin uptake peaked early and declined thereafter but remained elevated, compared with baseline. These stage-dependent changes of in vivo ^99mTc-annexin uptake were paralleled by changes in autoradiography and terminal deoxynucleotidyl-transferase–mediated dUTP nick-end labeling. Valsartan rats had longer RV failure–free survival than did monocrotaline rats and had reduced apoptosis. These changes were accompanied by commensurate delays in RV hypertrophy and RV dilation. Valsartan rats also had less fibrosis than monocrotaline rats at all disease stages. Conclusion: RV disease progression is associated with an early increase in RV apoptosis, as monitored using serial in vivo ^99mTc-annexin scintigraphy. Delay in RV disease progression by valsartan is accompanied by reduction in RV apoptosis. Apoptosis plays a role in RV disease progression and may be assessed by serial in vivo ^99mTc-annexin scintigraphy.

Key Words: right ventricle • heart failure • hypertrophy • apoptosis • fibrosis • annexin

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2009 50: 11A-12A. [Full Text]